The article argues that prohibition, if implemented with calibrated, evidence‑based enforcement and complementary interventions, can suppress consumption and associated harms despite demand inelasticity. It further contends that legalization-plus-excise-tax routinely raises availability and consumption in practice, undermining the simple economic claim that taxes simply substitute for enforcement.
— This reframes the legalization-versus-prohibition debate by making enforcement design — not just the binary choice — the central policy variable with measurable public‑health and fiscal consequences.
2026.04.20
78% relevant
This YouGov poll supplies fresh public‑opinion data relevant to debates over calibrated drug policy: high overall and near‑universal medical support (84%) plus majority recreational support (59%) indicate popular appetite for moving away from strict prohibition toward regulated frameworks—precisely the space occupied by 'calibrated prohibition' arguments. The age breakdown (45–64 most supportive) also informs which voter blocs policymakers will consider when designing or defending adjusted regulatory approaches.
Aporia
2026.04.07
88% relevant
The article cites a study of South Africa’s five‑week alcohol ban (July 2020) showing a ~14% drop in unnatural deaths and a temporary drop in violent crime (notably rape), which is direct empirical evidence that short, targeted bans can reduce mortality and violence — this maps onto the existing idea that calibrated prohibition-style policies can reduce harm.
2026.03.20
56% relevant
The newsletter highlights a peer‑reviewed Addiction study from Canada showing no detectable increase in deaths after an SCS closure and increased uptake of opioid‑agonist therapy — empirical evidence that feeds into debates about harm‑reduction versus calibrated prohibition strategies, resonating with the existing framing that some restrictions can reduce harms.
Adam Zivo
2026.03.19
80% relevant
The article’s summary of the Addiction study (Red Deer site closure vs. Lethbridge control) implies that removing supervised consumption sites did not increase deaths and coincided with higher uptake of opioid agonist therapy, supporting the existing idea that alternative regulatory or prohibition‑calibrated approaches plus treatment access can reduce harms better than relying on SCSs alone.
Charles Fain Lehman
2026.03.06
100% relevant
Charles Fain Lehman’s March 6, 2026 City Journal piece replying to Roland Fryer and invoking Becker–Murphy–Grossman economic theory and empirical drug‑harm outcomes.